Ken Griffin Perkinelmer Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	200 Added 2.41%	8,500 $1.03 Million
Q2 2024 Aug 14, 2024	SELL	N/A	-16,400 Reduced 66.4%	8,300 $1 Million
Q1 2024 May 15, 2024	BUY	N/A	1,100 Added 4.66%	24,700 $2.99 Million
Q4 2023 Feb 14, 2024	BUY	N/A	9,800 Added 71.01%	23,600 $2.86 Million
Q3 2023 Nov 14, 2023	SELL	$115.88 - $122.81 $1.41 Million - $1.5 Million	-12,200 Reduced 46.92%	13,800 $1.67 Million
Q2 2023 Aug 14, 2023	BUY	$0.0 - $137.11 $0 - $1.81 Million	13,200 Added 103.13%	26,000 $0
Q1 2023 May 15, 2023	BUY	$120.16 - $144.38 $408,544 - $490,892	3,400 Added 36.17%	12,800 $1.71 Million
Q4 2022 Feb 14, 2023	SELL	$119.0 - $147.98 $511,700 - $636,314	-4,300 Reduced 31.39%	9,400 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $160.96 $2.61 Million - $3.56 Million	-22,100 Reduced 61.73%	13,700 $1.65 Million

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.